Emilia Gabriela Sardo2026-03-27T14:38:22+01:00

Emilia Gabriela Sardo

Member of the Cancer Profiling Research Line

Email: emiliagabriela.sardo@uvic.cat

ORCID: 0000-0002-1764-0528

Scientific Profile: URECERCA

I am a Medical Oncologist who graduated in Medicine from the Universidad Católica de Córdoba. After completing my residency training, I pursued a fellowship at the Hospital Universitario Vall d’Hebron and subsequently undertook an observership at the Università degli Studi della Campania Luigi Vanvitelli in Naples, Italy.

I currently work as a Consultant Medical Oncologist at the Hospital Universitari de Vic, where I am involved in clinical work and clinical research, alongside teaching activities. My clinical practice focuses on breast cancer and gynaecological cancers, allowing me to integrate patient care with research in a direct and meaningful way. I am actively involved in the training of medical residents and in undergraduate teaching at the Universitat de Vic – Central University of Catalonia, where I serve as Associate Professor of Oncology.

Since September 2022, I am pursuing a PhD in Medicine and Biomedical Sciences at the Universitat de Vic – Central University of Catalonia, supported by an Industrial Doctorate fellowship. My research focuses on translational research in gynaecological cancers, with a particular emphasis on endometrial cancer. In parallel, I am also enrolled in a postgraduate Expert Programme in gynaecological cancers at the Universitat de Girona, further strengthening my specialised training in this field.

My last happenings:

From Subversive Labs to Biodesign Literate Curricula: Rethinking Biodesign Education

Authors: Orcajada M. A., Rognoli V, Crespo-Santiago J, Ordóñez I. Biotechnology design, Cambridge University Press, 2026. Results in Engineering, 2026. DOI:https://doi.org/10.1017/S2977905726100390 Keywords: biodesign; biodesign literacy; subversive; labs; education. Funding: This research was partially funded by the Erasmus+ programme Centres of Vocational Excellence, “Transforming Education Area and Competency Hub for Sustainable Development” (project acronym: TEACH4SD). The content of this publication does not reflect the official opinion of the European Union; responsibility for the information and views expressed lies entirely with the author(s). Read More Biodesign has gained prominence over the past two decades yet remains conceptually hazy and institutionally [...]

November 6, 2026|

TR2Lab Invited at Congresso de Feridas Guarda 2026

Clara Masó Albareda, PhD student at TR2Lab, was invited to participate in the Congresso de Feridas Guarda 2026, held in Guarda, Portugal, on 14–15 October 2026. As part of the scientific programme, Clara delivered an invited lecture in the session “Tempo da Inovação – Hot Topics”, where she presented the latest findings from her doctoral research on regenerative therapies and their potential applications in wound healing. Her presentation provided attendees with an overview of the most recent results of her PhD project and highlighted the ongoing research being conducted at TR2Lab. In addition to the lecture, Clara [...]

November 4, 2026|

Exploring the Potential of Phygital Bone as a Synthetic Surrogate for Forensic Bone Trauma

Authors: Crespo-Santiago, J; Jordana, X; Gesualdo, M; Álvarez, A; Mallafré, H; Otero-Viñas, M; Rzymelka V; Andreu C; Garrido X; Schwab N; Galtés I. Exploring the potential of Phygital Bone as a synthetic surrogate for forensic bone trauma.   Scientific Reports, 2026. DOI: https://doi.org/10.21203/rs.3.rs-10206802/v1 Keywords: Health sciences/Anatomy; Physical sciences/Engineering; Physical sciences/Materials science; Health sciences/Medical research; Bone trauma; Synthetic bone surrogate; Forensic trauma reconstruction; Bone biomechanics; 3D-printed bone model. Funding: This research was funded by: AEI Clusters Spanish Ministry for Industry and Tourism (AEI-010500-2024-18), Llavor AGAUR Gencat (2023 LLAVOR 0005), and Proyectos de Generación de Conocimiento, Agencia Estatal de Investigación (PID2021-124112NB-100). Read More [...]

November 2, 2026|
Go to Top